Folinic Acid, Fluorouracil, and Oxaliplatin Therapy for Recurrent Esophageal Cancer with Syndrome of Inadequate Antidiuretic Hormone Secretion (SIADH) After Preoperative Cisplatin/5-Fluorouracil Therapy

Ryoko Futai; Tomoo Yoshie; Tsuyoshi Sanuki; Yuta Inoue; Tetsuyuki Abe; Ayaka Sasaki; Takao Iemoto; Hiroki Hayashi; Takayuki Ose; Teruhisa Morikawa

doi:10.12659/AJCR.935121

15 February 2022: Articles

Folinic Acid, Fluorouracil, and Oxaliplatin Therapy for Recurrent Esophageal Cancer with Syndrome of Inadequate Antidiuretic Hormone Secretion (SIADH) After Preoperative Cisplatin/5-Fluorouracil Therapy

Unusual or unexpected effect of treatment, Rare disease

Ryoko Futai ^A* , Tomoo Yoshie ^B , Tsuyoshi Sanuki ^B , Yuta Inoue ^B , Tetsuyuki Abe ^B , Ayaka Sasaki ^B , Takao Iemoto ^B , Hiroki Hayashi ^B , Takayuki Ose ^B , Teruhisa Morikawa ^B

DOI: 10.12659/AJCR.935121

Am J Case Rep 2022; 23:e935121

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

Figure 3. Serum sodium concentration and creatinine levels before and after chemotherapy.

Back to the Article

Folinic Acid, Fluorouracil, and Oxaliplatin Therapy for Recurrent Esophageal Cancer with Syndrome of Inadequate Antidiuretic Hormone Secretion (SIADH) After Preoperative Cisplatin/5-Fluorouracil Therapy

Your Privacy